CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Collagen extracellular matrix promotes gastric cancer immune evasion by activating IL4I1-AHR signaling.
Collagen extracellular matrix promotes gastric cancer immune evasion by activating IL4I1-AHR signaling.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们的研究揭示了一种新机制,即胶原 ECM 通过激活 IL4I1-AHR 信号促进胃癌免疫逃逸,导致 CAR-T 细胞耗竭。靶向该通路可能潜在增强 CAR-T 细胞疗法在胃癌中的疗效。
胃癌(GC)仍然是全球重大的健康挑战,预后较差,部分原因在于其能够逃避免疫系统的攻击。细胞外基质(ECM),尤其是胶原蛋白,在肿瘤免疫逃逸中发挥关键作用,但其潜在机制尚未完全阐明。本研究探讨胶原蛋白ECM通过激活IL4I1-AHR信号通路促进胃癌免疫逃逸的作用。
我们将胃癌细胞在3D胶原凝胶中培养,并通过与HER2特异性CAR-T 细胞共培养来评估其免疫逃逸能力。分析了IL4I1及其代谢物的表达,并探讨了整合素v 1在介导胶原效应中的作用。此外,在体外和体内评估了IL4I1诱导的AHR激活对CAR-T 细胞耗竭的影响。
我们发现,在胶原蛋白上培养的胃癌细胞对CAR-T 细胞细胞毒性表现出增强的耐药性,这与CAR-T 细胞上免疫检查点分子上调和效应细胞因子下调相关。这与IL4I1表达增加有关,而IL4I1表达在3D胶原环境中进一步由整合素v 1信号诱导。IL4I1代谢产物,尤其是KynA,通过激活AHR通路促进CAR-T 细胞耗竭,导致细胞毒性和肿瘤生长抑制降低。
Gastric cancer (GC) remains a significant global health challenge with poor prognosis, partly due to its ability to evade the immune system. The extracellular matrix (ECM), particularly collagen, plays a crucial role in tumor immune evasion, but the underlying mechanisms are not fully understood. This study investigates the role of collagen ECM in promoting immune evasion in gastric cancer by activating the IL4I1-AHR signaling pathway.
We cultured gastric cancer cells in 3D collagen gels and assessed their immune evasion capabilities by co-culturing with HER2-specific CAR-T cells. The expression of IL4I1 and its metabolites was analyzed, and the role of integrin v 1 in mediating the effects of collagen was explored. Additionally, the impact of IL4I1-induced AHR activation on CAR-T cell exhaustion was evaluated, both in vitro and in vivo.
We found that gastric cancer cells cultured on collagen exhibited increased resistance to CAR-T cell cytotoxicity, which was associated with upregulated immune checkpoint molecules and downregulated effector cytokines on CAR-T cells. This was linked to increased IL4I1 expression, which was further induced by integrin v 1 signaling within the 3D collagen environment. IL4I1 metabolites, particularly KynA, promoted CAR-T cell exhaustion by activating the AHR pathway, leading to decreased cytotoxicity and tumor growth inhibition.
Our study reveals a novel mechanism by which the collagen ECM facilitates immune evasion in gastric cancer through the activation of IL4I1-AHR signaling, contributing to CAR-T cell exhaustion. Targeting this pathway could potentially enhance the efficacy of CAR-T cell therapy in gastric cancer.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。